Not Yet Recruiting NA INTERVENTIONAL 2-arm
NCT07423897
Consumer Health Study Aims to Evaluate the Safety, Tolerability and Impact of ED02 Probiotic Supplement on Gastrointestinal Outcomes
A Randomized, Double-Blind, Placebo-Controlled Pilot Study Evaluating the Safety, Tolerability and Impact of Synbiotic Health's Bifidobacterium Pseudocatenulatum ED02 Probiotic Supplement on Gastrointestinal Outcomes
Sponsor: People Science, Inc.
Conditions
Gastrointestinal Gut Health
Interventions
Bifidobacterium pseudocatenulatum Placebo
Updated 1 time since 2026 Last updated: Feb 13, 2026 Started: Mar 4, 2026 Primary completion: Jun 17, 2026 Completion: Aug 31, 2026
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
A NA clinical study on Gastrointestinal and Gut Health, this trial is actively recruiting participants. The trial is conducted by People Science, Inc. and has accumulated 1 data snapshot since 2026. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
1 version recorded Not Yet Recruiting — NA
[monthly]
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- People Science, Inc.
- Synbiotic Health
Data source: Synbiotic Health
For direct contact, visit the study record on ClinicalTrials.gov .